Glechoma hederacea L. (Labiatae) has been used in folk medicine to treat various ailments for centuries. We investigated the effects of G. hederacea extract on melanogenesis in B16 melanoma cells. It significantly reduced both the cellular melanin content and tyrosinase activity in a concentration-dependent manner. An MTT assay did not reveal any obvious cytotoxicity. Furthermore, we found that G. hederacea extract decreased tyrosinase and microphthalmia-associated transcription factor protein expression, but did not inhibit tyrosinase-related protein-1 and tyrosinase-related protein-2 expression. RT-PCR analysis indicated that the antimelanogenic effect of G. hederacea extract might be due to inhibition of tyrosinase gene transcription. Moreover, this effect is regulated via suppression of microphthalmia-associated transcription factor protein expression. Our data indicate that G. hederacea extract inhibits melanin synthesis in B16 melanoma cells but is not cytotoxic. Hence it might prove a useful therapeutic agent for treating hyperpigmentation and an effective component of whitening cosmetics.
In mammals, skin pigmentation is due to the synthesis and distribution of melanin. Melanin is a mixture of pigmented biopolymers synthesized by melanocytes. 1) Melanin-containing granules are known as melanosomes, and are exported from melanocytes to adjacent keratinocytes.
2) Melanocytes produce two types of melanin: black-to-brown eumelanin and red-to-yellow pheomelanin.
3) Melanin synthesis, called melanogenesis, is a complicated physiological process that is regulated by melanogenic enzymes. Three melanocytespecific enzymes, tyrosinase, tyrosinase-related protein-1 (TRP-1), and dopachrome tautomerase, also known as TRP-2, are involved in melanogenesis. 4) Tyrosinase, the rate-limiting enzyme in melanogenesis, catalyzes the two initial steps of this process, the hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA) and the oxidation of DOPA to DOPAquinone. 5) TRP-2 catalyzes the conversion of DOPAchrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), 6, 7) and TRP-1 catalyses the oxidation of DHICA to indole-5,6-quinone-2-carboxylic acid. 8, 9) Melanin production plays an important role in preventing UV irradiation. Various signaling pathways mediate melanin production, and a cAMP-dependent pathway appears to be the major pathway in UVdependent stimulation of melanin production. 10) When keratinocytes in the skin are exposed to UV irradiation, -melanocyte-stimulating hormone (-MSH), a peptide hormone, is produced, and is released as a paracrine factor.
11) Secreted -MSH binds to the melanocortin 1 receptor, which activates adenylate cyclase through G proteins to increase the levels of intracellular cAMP. 12) cAMP activates protein kinase A, which phosphorylates the transcription factor cAMP response element-binding protein at Ser133 and increases the expression of microphthalmia-associated transcription factor (MITF). MITF, characterized by an essential basic helix-loophelix leucine zipper structure, is believed to regulate melanocyte pigmentation, proliferation, and survival. 13) It mediates the transcriptional activation of pigmentation genes, such as tyrosinase, TRP-1, and TRP-2, by binding with the M-box in the promoter regions of these genes. 14, 15) Although melanin production plays an important role in protecting the skin against damage due to UV irradiation, excessive melanin biosynthesis causes several skin disorders, including melasma, lentigines, freckles, nevus, and age spots. 16) Inhibition of tyrosinase activity is related to anti-melanogenesis, and many tyrosinase inhibitors are used in the treatment of hyperpigmentation, including kojic acid, 17) arbutin, 18) and linoleic acid. 19) However, many of the currently used skin-whitening agents exhibit toxicity toward melanocytes and produce adverse side effects. Thus, there is a need for the development of depigmenting agents.
Glechoma hederacea L. (Labiatae), commonly known as ground ivy, creeping Charlie, or gill-over-the-ground, is a perennial hairy herb with a creeping stem. It is distributed widely in Asia, Europe, and America, where it grows in shady areas, on waste ground, in dry ditches, near fences and hedges, and on the sides of moist meadows. 20) It has been used as a folk medicine for centuries in the treatment of various ailments, e.g., asthma, bronchitis, colds, diabetes, and inflammation. 21) In addition, it has been reported that G. hederacea extract has anti-oxidant activity, 22) but no report on melanin biosynthesis or tyrosinase activity has been demonstrated. Hence we focused on the whitening effect y To whom correspondence should be addressed. Tel: +81-18-884-6074; Fax: +81-18-884-6443; E-mail: sugiyama@med.akita-u.ac.jp of this plant and evaluated its biological effect on melanogenesis as a new activity. In this study, we investigated the inhibitory effect of G. hederacea on melanin biosynthesis and the molecular mechanism of that effect.
Materials and Methods
Preparation of G. hederacea extract. Glechoma hederacea was collected at growth phase early in the morning, while it was watery. Weeds were removed from it. Soils and sands that adhered to the roots were removed, and it was washed under running tap water 4 or 5 times. The whole plant was cut to about 2-cm pieces and blended in a blender with running tap water (45 g, 100 mL) at room temperature. Then the supernatant was collected and the dregs were discarded. The supernatant was stirred slowly until it separated. When it became clear, it was filtered with cotton bags and samples were stored at 4 C. Debris was removed by centrifugation at 5;000 g for 10 min before use. The samples were concentrated using a rotary evaporator (70 C, 3 h) (EYELA, Tokyo, Japan) to measure the concentration. The concentrated samples were dissolved with medium (DMEM without phenol red, Sigma, St. Louis, MO) completely for use.
Cell culture. B16F10 melanoma cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Sigma) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Invitrogen Corp., Carlsbad, CA), 100 U/mL of penicillin, 0.1 mg/mL of streptomycin, and 0.25 mg/mL of amphotericin B (antibiotic-antimycotic; Invitrogen) in a humidified atmosphere containing 5% CO 2 in air at 37 C. The cell passage number in the dish was 12-15, and the culture medium was changed every 2 d.
Melanin quantification. B16F10 melanoma cells were seeded at a density of 5 Â 10 4 cells per well in 6-well culture plates and incubated for 24 h. They were then incubated with and without G. hederacea extract (0.1, 0.2, 0.5, 1 mg/mL) in the medium (DMEM without phenol red, Sigma) for 72 h. The melanin content was measured as described previously, 23) with some modifications. After treatment, the cells were detached by incubation in trypsin/EDTA. They were collected in a test tube and washed twice with PBS. The melanin was then extracted using 2 M NaOH at 100 C for 30 min. The melanin content was measured by measuring the absorbance at 405 nm (Infinite 200, TECAN, Kanagawa, Japan).
Cell viability assay. Cell viability was determined by a modification of the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. B16F10 melanoma cells (1 Â 10 5 cells/mL) were cultured in 96-well microplates with various concentrations of G. hederacea extract for 72 h. After treatment, the cells were treated with 10 mL of 5.5 mg/mL MTT and incubated at 37 C for 4 h. A 90-mL aliquot of the extraction solution (40% N,N-dimethylformamide, 2% CH 3 COOH, 20% sodium dodecyl sulfate, and 0.03 M HCl) was added to each well and mixed thoroughly by overnight agitation at room temperature. Cell viability was determined by measuring the optical density at 570 nm using a Model 550 microplate reader (Bio-Rad, Hercules, CA).
Mushroom tyrosinase activity assay. Mushroom tyrosinase activity assay was performed in the 96-well microplates. The L-DOPA oxidation activity of tyrosinase was measured by spectrophotometry as described previously, 24) with some modifications. Briefly, 160 mL of 5 mM L-DOPA (in 100 mM sodium phosphate buffer pH 6.8) and 20 mL of the same buffer with and without the test sample were placed in the wells of a 96-well microplate, and then 20 mL of mushroom tyrosinase (200 units/mL) were mixed into each well at 37 C over 30 min. The absorbance at 475 nm was measured (Infinite 200, TECAN, Kanagawa, Japan).
Cellular tyrosinase activity assay. Tyrosinase activity was analyzed by spectrophotometry following the oxidation of DOPA to DOPAchrome. B16F10 melanoma cells (5 Â 10 4 cells/well) were plated in 60-mm diameter dishes and incubated at 24 h. They were then treated with various concentrations of G. hederacea extract for 72 h. They were washed with PBS twice and lysed with 100 mM sodium phosphate buffer (pH 6.8) containing 1% Triton X-100 and 0.1 mM phenylmethylsulfonyl fluoride. They were then disrupted, and lysates were clarified by centrifugation at 13,000 rpm for 20 min at 4 C. After protein quantification and adjustment of the protein concentration with lysis buffer, 100 mL of each lysate (each containing 100 mg the protein) was aliquoted into a 96-well plate, and 100 mL of 5 mM DOPA was then added to each well. Following incubation at 37 C for 2 h, the absorbance was measured at 475 nm (Infinite 200, TECAN, Kanagawa, Japan).
Western blotting analysis. B16F10 melanoma cells were cultured in 60-mm diameter dishes with and without various concentrations of G. Hederacea extract (0.1, 0.2, 0.5, 1 mg/mL) for 72 h. The cells were then lysed in a buffer (1% NP40, 0.5% deoxycholic acid sodium salt, 10% SDS, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 mg/mL of leupeptin, and 1 mg/mL of pepstatin A). Proteins (50 mg) were resolved by 10% SDS-polyacrylamide gel electrophoresis and transferred electrophoretically to polyvinylidene difluoride membranes. The membranes were blocked overnight in 5% skim milk in TBST (20 mM Tris-HCl pH 7.4, 100 mM NaCl, and 0.1% Tween 20) buffer at 4 C. After a brief wash in TBST buffer, they were then incubated for 3 h with a primary antibody: goat anti-tyrosinase antibody (1:500), anti-TRP-1 antibody (1:500), anti-MITF antibody (1:500), or rabbit anti-TRP-2 antibody (1:500) (Santa Cruz Biotechnology, CA). After incubation, the membranes were rinsed 5 times with TBST buffer and incubated for 2 h with a secondary antibody: anti-goat IgG (1:50,000) or anti-rabbit IgG (1:2000) (Sigma). Then they were rinsed 5 times with TBST buffer. The loading control was measured using anti--actin antibody. Bound antibodies were detected using the ECL or ECL Prime Western Blotting Detection System (GE Healthcare, London). Bands were scanned by GS-800, and band intensities were quantified by measuring optical densities with Quantity One software (Bio-Rad).
Reverse transcription-polymerase chain reaction (RT-PCR).
B16F10 melanoma cells were incubated with and without G. Hederacea extract (0.1, 0.2, 0.5, or 1 mg/mL) for 72 h. After treatment, total RNA was extracted using RNAiso Plus (TaKaRa, Otsu, Japan). cDNA was synthesized using 1 mg of total RNA with SuperScript III FirstStrand Synthesis SuperMix (Invitrogen). cDNA amplification was performed using the following primers: tyrosinase, C. The PCR products were separated on 1.5% agarose gels and stained with ethidium bromide. The bands were analyzed using Quantity One software (Bio-Rad).
Statistical analysis. Values were expressed as mean AE standard deviation (SD) of three different experiments. To check for quantitative differences between the groups, analysis of variance (ANOVA) and the Tukey-Kramer Multiple Comparison tests were performed. p < 0:05 was considered as statistically significant. All analysis were performed using JMP 8 (SAS Institute, Cary, NC).
Results

Effect of G. hederacea extract on melanin production and cell proliferation
In this study, we used murine B16F10 melanoma cells as the cell model in assaying the inhibitory effect of G. hederacea extract on melanogenesis. To investigate the effect of G. hederacea extract on melanin production, the melanin content of G. hederacea extracttreated B16F10 melanoma cells was quantified. As shown in Fig. 1A , melanin levels were reduced in a concentration-dependent manner by G. hederacea extract treatment. Then we investigated the effect of the G. hederacea extract on B16F10 melanoma cell proliferation by MTT assay. As shown in Fig. 1B , the extract had no significant cytotoxic effect on B16F10 cells at the concentrations used. These results indicate that G. hederacea extract exerts antimelanogenic effects on B16F10 melanoma cells without inducing cytotoxicity.
Effect of G. hederacea extract on mushroom tyrosinase activity
To determine whether G. hederacea extract affects tyrosinase activity directly, we performed a mushroom tyrosinase assay using L-DOPA as substrate and mushroom tyrosinase as enzyme source. Tyrosinase is a key enzyme catalyzing the rate-limiting step in melanin biosynthesis. Kojic acid, a well-known inhibitor of tyrosinase, inhibited tyrosinase activity by 11%, 49%, 69%, and 83% at concentrations of 0.1, 0.3, 1, and 3 mM, respectively. These results confirmed that kojic acid inhibits mushroom tyrosinase in a concentration-dependent manner as positive control (Fig. 2A) . However, as shown in Fig. 2B , G. hederacea extract did not exert a significant inhibitory effect on L-DOPA oxidation by mushroom tyrosinase. These results suggest that kojic acid displayed inhibitory effects on mushroom tyrosinase activity, while G. hederacea extract did not directly inhibit mushroom tyrosinase activity in vitro.
Inhibitory effect of G. hederacea extract on B16F10 melanoma cellular tyrosinase activity Based on these results, G. hederacea extract displayed no inhibitory effect on mushroom tyrosinase activity, suggesting that it does not directly affect tyrosinase activity. Hence, to examine the possible mechanism of the anti-melanogenesis effect of G. hederacea extract, we measured cellular tyrosinase activity. Cells were treated with various concentrations of G. hederacea extract for 3 d, and lysates of the cells treated with G. hederacea extract were used as enzyme source. As shown in Fig. 3 , tyrosinase activity in the cultured B16F10 melanoma cells was suppressed in a concentration-dependent manner by the G. hederacea extract.
Western blotting of the expression of tyrosinase and related proteins in G. hederacea extract-treated cells
To determine whether the antimelanogenic effect of G. hederacea extract was related to melanogenic proteins such as tyrosinase and related proteins TRP-1 and TRP-2, we performed Western blotting using the cell lysate of B16F10 melanoma cells treated with G. hederacea extract. As shown in Fig. 4A and B, tyrosinase protein levels were significantly decreased by G. hederacea extract treatment, in a concentration-dependent manner. In contrast, the protein levels of TRP-1 and TRP-2 exhibited no significant changes in the G. hederacea extract-treated B16F10 melanoma cells (Fig. 4A , C, and D). -Actin was used as internal control, and the levels of it were not changed by the G. hederacea extract treatment. These results indicate that the G. hederacea extract decreased melanogenesis by downregulating tyrosinase protein expression.
Effect of G. hederacea extract on the gene expression of tyrosinase and related proteins
Furthermore, in view of the data, we performed RT-PCR to examine the effect of the G. hederacea extract on the gene transcription of tyrosinase and related proteins. As shown in Fig. 5A and B, tyrosinase mRNA levels significantly decreased, in a concentration-dependent manner, but TRP-1 and TRP-2 gene expression did not change in this experiment (Fig. 5A, C, and D) . In addition, the gene expression of GAPDH, which was used as internal control, exhibited no change. In accordance with its effect on protein expression, the G. hederacea extract also reduced the mRNA expression levels of tyrosinase in B16F10 melanoma cells.
Effect of G. hederacea extract on MITF expression
MITF has been reported to bind to the M-box within the tyrosinase promoter and in this way to regulate , and 1 mg/mL) of the G. hederacea extract for 72 h. Cell lysates were subjected to Western blotting using antibodies against tyrosinase, TRP-1, and TRP-2. Western blotting was performed using 50 mg of each sample. The loading control was assessed using -actin antibody. The relative intensities of tyrosinase (B), TRP-1 (C), and TRP-2 (D) expression compared with the -actin expression were determined using Quantity One software. Values represent the mean AE SD for three independent experiments. ANOVA determined that there were significant differences among the groups in Fig. 4B (p < 0:001) . Values not sharing the same letter are significantly different from each other (p < 0:05, Tukey-Kramer multiple comparisons test). tyrosinase gene expression. 14, 15) Since MITF controls tyrosinase protein levels, we investigated the effect of the G. hederacea extract on MITF protein levels by Western blotting. As shown in Fig. 6A and B, MITF protein levels decreased in a concentration-dependent manner. The diminished levels of MITF protein were perhaps caused by decreased MITF gene expression. Hence we examined to determine whether the G. hederacea extract would have an effect on MITF transcription. RT-PCR was performed using primer specific for MITF. As shown in Fig. 6C and D, we did not observe any significant change in the levels of MITF PCR fragments in the G. hederacea extract-treated cells, whereas the levels of MITF protein decreased significantly.
Discussion
In this study, we investigated to determine whether G. hederacea extract has a hypopigmentation effect in B16F10 melanoma cells, and found that it strongly downregulated melanin synthesis without showing significant cytotoxicity. Melanin production occurs predominantly in the melanosomes, which are lysosomelike structures of melanocytes. Melanin is packaged and delivered to the keratinocytes by melanosomes. The two types of melanin, pheomelanin and eumelanin, are different not only in color but also in the size, shape, and the packing of their granules. 25) Both pheomelanin and eumelanin are produced from the same precursor, tyrosine, in a common tyrosinase-dependent pathway. Melanogenesis is known to be regulated by the tyrosinase gene family, which includes tyrosinase, TRP-1, and TRP-2.
4) Tyrosinase controls two key steps in the melanin synthesis pathway by catalyzing the hydroxylation of tyrosine to DOPA, followed by the oxidation of DOPA to DOPAquinone, 5) and thus melanin production is correlated with the expression level and the catalytic activity of tyrosinase. To investigate the mechanism of G. hederacea extract in inhibiting melanogenesis, first we investigated to determine whether G. hederacea extract inhibits tyrosinase activity directly in cell-free assay systems. We used mushroom tyrosinase as enzyme source. In this assay, kojic acid was used as positive control. It has been reported to affect melanin synthesis in melanocytes and melanoma cells. 26) We observed that the G. hederacea extract did not inhibit the L-DOPA oxidation activity of mushroom tyrosinase, suggesting that the antimelanogenic effect of the G. hederacea extract was not due to direct inhibition of tyrosinase enzyme activity. In contrast, we performed a cellular tyrosinase activity assay using G. hederacea extract-treated cell lysates as enzyme source, and cellular tyrosinase activity was inhibited in a concentration-dependent manner. These Total RNA was extracted and cDNA was prepared. Equivalent amounts of cDNA were amplified using primers specific for tyrosinase, TRP-1, TRP-2, and GAPDH. GAPDH mRNA levels were determined as control. The relative intensities of tyrosinase (B), TRP-1 (C), and TRP-2 (D) expression compared with the total GAPDH expression were determined using Quantity One software. Values represent the mean AE SD for three independent experiments. ANOVA determined that there were significant differences among the groups results indicate that the G. hederacea extract probably downregulated tyrosinase expression, but had no effect on tyrosinase catalytic activity.
To investigate further the anti-melanogenesis mechanism of the G. hederacea extract in B16F10 melanoma cells, Western blotting was done. The results indicate that the G. hederacea extract inhibited tyrosinase protein expression in a concentration-dependent manner, but the G. hederacea extract had no influence on TRP-1 or TRP-2 expression. Next, we evaluated the effects of G. hederacea extract on tyrosinase, TRP-1, and TRP-2 mRNA expression. In accordance with the changes at the protein level, the G. hederacea extract inhibited tyrosinase mRNA expression in a concentration-dependent manner, but did not alter TRP-1 and TRP-2 mRNA levels. Thus, the present study clearly indicates that the G. hederacea extract inhibited tyrosinase expression at the transcription level, which resulted in anti-melanogenesis in the B16F10 melanoma cells.
MITF is believed to be a major regulator gene in melanocyte development and differentiation. The MITF gene, encoding a basic-helix-loop-helix-leucine zipper transcription factor, is expressed in melanocytes, the retinal pigment epithelium, mast cells, osteoclasts, and melanoma cells. [27] [28] [29] The MITF protein binds to specific consensus DNA sequences in the promoter regions of various target genes, regulating several processes, including differentiation, proliferation, migration, invasion, and tumorigenesis. 30, 31) Moreover, MITF is known to be a transcription factor of the melanogenic enzymes tyrosinase, TRP-1, and TRP-2. Next we investigated the effect of the G. hederacea extract on the mRNA and protein levels of MITF. The results indicated that the G. hederacea extract decreased MITF protein levels but did not decrease MITF mRNA levels. Since MITF binds to a highly conserved motif to activate tyrosinase gene transcription, reduced expression of tyrosinase must have been responsible for the inhibition of MITF protein expression in the G. hederacea extract-treated cells. The reason MITF downregulation did not reduce TRP-1 and TRP-2 expression remains unclear. Our results are in accordance with several reports. Pyrroloquinoline quinone inhibited tyrosinase expression, but not TRP-1 or TRP-2 expression, in -MSH-stimulated B16 melanoma cells. 32) Fermented Viola mandshurica has also been reported to decrease MITF and tyrosinase protein expression without affecting the expression of TRP-1 or TRP-2. 33) Many signal transduction pathways have been found to balance melanin production. Mitogen-activated protein kinase pathways, particularly the extracellular signal-regulated kinase (ERK) 1/2 pathway, are perhaps involved in MITF regulation. 34, 35) Significant MITF degradation occurs after phosphorylation of it at serine 73 by ERK, leading to ubiquitin-dependent proteasomal degradation. 36) In the present study, we found that the G. hederacea extract reduced MITF protein expression but had no effect on transcription of it. The mechanism might be related to ERK phosphorylation. Future studies should be conducted to elucidate this mechanism.
Here we report a depigmenting effect of G. hederacea, but we did not investigate the active constituent. Several studies have reported that the chemical composition of G. hederacea includes alkaloids, sesquiterpenoids, triterpenoids, flavonoid glycosides, and rosmarinic acid, [20] [21] [22] [37] [38] [39] but there is no report on the active constituent of G. hederacea as to anti-melanogensis. Further work is needed to define it.
Medicinal tea and liquor made with G. hederacea have been used recently. In that G. hederacea has high water solubility, perhaps it can be used as an active ingredient of skin whitening agents for external use, such as milky lotion, cream, and skin lotion. We investigated the effect of G. hederacea on anti-melanogensis in this study, but clinical application as a whitening agent remains to be investigated.
In conclusion, the present study found the G. hederacea extract inhibited cellular melanin biosynthesis and tyrosinase activity in B16 murine melanoma cells by suppressing MITF, leading to tyrosinase downregulation at the transcriptional level. These results indicate that the G. hederacea extract is an effective inhibitor of melanogenesis and be useful as a therapeutic treatment for skin hyperpigmentation disorders.
